Diagnos Laboratorium Utama Tbk. vs XL Axiata Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp226 (market cap 308B, 21.3K 24h volume), while XL Axiata Tbk. trades at Rp2,520 (market cap 46.41T, 192.2K 24h volume). The key difference: XL Axiata Tbk. is far larger — about 150.7× Diagnos Laboratorium Utama Tbk.'s market cap, and XL Axiata Tbk. is more actively traded (192.2K versus 21.3K). Which is the better fit depends on your goals.
| DGNS | EXCL | |
|---|---|---|
Market Cap | 308B | 46.41T |
Volume | 21.3K | 192.2K |
Lot | 213 | 1.92K |
Turnover | 4.86M | 486.26M |
Average Price | 228.07 | 2,529.99 |
Value | 4.86M | 486.26M |
Indicative Equilibrium Price | 230 | 2,550 |
Indicative Equilibrium Volume | 110 | 45.3K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Read more on EXCL →